Freudenberg Medical Unveils Second Production Facility in Costa Rica

Grand Opening of Freudenberg Medical's second operation in Costa Rica. Pictured: Keith Kiernan, Chief Commercial Officer; Robin Blair, Freudenberg Real Estate; Roger Gomez, General Manager Freudenberg Medical Costa Rica; Michael McGee, CEO Freudenberg Medical; Paula Guillen, Supply Chain Manager, Freudenberg Medical (Image Courtesy: Business Wire)

Freudenberg Medical, a global contract design and manufacturing (CDMO) partner to the medical device and biopharma industry, has officially inaugurated its second production facility in Costa Rica. The new site represents a USD 25 million investment to strengthen the company’s presence in one of the world’s most dynamic MedTech near-shoring hubs. “Costa Rica has become […]

Costa Rica’s Emergence as a Main Player in the Crypto World

Costa Rica's Emergence as a Main Player in the Crypto World

The way that cryptocurrencies have emerged as an important part of the global financial situation has been a thrilling sight in recent years. As people have begun to realize the freedom this gives them to handle their money in a way that suits them, it has also led to Costa Rica finding a place among […]

First Cessna Citation Longitude Delivered to Central America, Expanding Flagship Jet Fleet

First Cessna Citation Longitude Delivered to Central America, Expanding Flagship Jet Fleet

Textron Aviation Inc., a Textron Inc. company, announced on May 29th the first delivery of its flagship Cessna Citation Longitude super-midsize business jet into Central America. The long-time Citation customer is based in Costa Rica and plans to use the aircraft for business and personal use. “The Citation Longitude is a game-changer for customers. Its extended range and […]

Botanical Solution Inc. Announces Closing of Series A Funding

Botanical-Solution-Inc.-BSI-CEO-Gaston-Salinas-discusses-the-industrial-production-and-expanded-use-of-Gold-Standard-vaccine-adjuvant-QS-21

Botanical Solution Inc. (BSI) announced it has closed another $7.6 million financing, as part of Series A, that will fund the commencement of in-house production of QS-21, pharmaceutical grade vaccine adjuvant. Using cost-effective and scalable proprietary methods, BSI will expand QS-21 use in broader vaccine applications. Mr. Salinas made the announcement at Harvard University’s Global […]